Central opioidergic neurotransmission in complex regional pain syndrome

Neurology

Volumn 75, Issue 2, 2010, Pages 129-136

  Klega, A ^a   Eberle, T ^a   Buchholz, H G ^a   Maus, S ^a   Maihofner C ^b   Schreckenberger, M ^a   Birklein, F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DULOXETINE; FLUOROETHYLDIPRENORPHINE F 18; OPIATE RECEPTOR; PREDNISOLONE; PREGABALIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; COMORBIDITY; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; LIMB INJURY; MALE; NEUROTRANSMISSION; PAIN ASSESSMENT; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR POTENTIAL; TEMPORAL CORTEX;

EID: 77954706653     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e7ca2e     Document Type: Article

References (38)

1. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 2001;57:2179-2184. (Pubitemid 34016448)
2. Maihofner C, Handwerker HO, Birklein F. Functional imaging of allodynia in complex regional pain syndrome. Neurology 2006;66:711-717.
3. Wasner G, Schattschneider J, Heckmann K, Maier C, Baron R. Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value. Brain 2001;124:587-599.
4. van Rijn MA, Marinus J, Putter H, van Hilten JJ. Onset and progression of dystonia in complex regional pain syndrome. Pain 2007;130:287-293. (Pubitemid 46977120)
5. Harden RN, Bruehl S, Stanos S, et al. Prospective examination of pain-related and psychological predictors of CRPS-like phenomena following total knee arthroplasty: a preliminary study. Pain 2003;106:393-400.
6. Bodnar RJ, Klein GE. Endogenous opiates and behavior: 2005. Peptides 2006;27:3391-3478.
7. Baumgärtner U, Buchholz H, Bellosevich A, et al. High opiate receptor binding potential in the human lateral pain system. Neuroimage 2006;30:692-699.
8. Zubieta JK, Smith YR, Bueller JA, et al. Regional mu opi-oid receptor regulation of sensory and affective dimensions of pain. Science 2001;293:311-315.
9. Sprenger T, Valet M, Boecker H, et al. Opioidergic activation in the medial pain system after heat pain. Pain 2006; 122:63-67.
10. Ribeiro SC, Kennedy SE, Smith YR, et al. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1264-1280.
11. Kennedy SE, Koeppe RA, Young EA, Zubieta J. Dysregu-lation of endogenous opioid emotion regulation circuitry in major depression in women. Arch Gen Psychiatry 2006; 63:1199-1208.
12. Leknes S, Tracey I. A common neurobiology for pain and pleasure. Nat Rev Neurosci 2008;9:314-320.
13. Willoch F, Schindler F, Wester HJ, et al. Central post-stroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study. Pain 2004;108:213-220.
14. Harris RE, Clauw DJ, Scott DJ, et al. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007;27:10000-10006.
15. Wester HJ, Willoch F, Tölle TR, et al. 6-O-(2-[18F]fluoroethyl)-6-O- desmethyldiprenorphine ([18F] DPN): synthesis, biologic evaluation, and comparison with [11C]DPN in humans. J Nucl Med 2000;41:1279-1286.
16. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med 2007;8:326-331.
17. Stein C, Mendl G. The German counterpart to McGill Pain Questionnaire. Pain 1988;32:251-255.
18. Herrmann C, Buss U, Snaith RP. HADS-D Hospital Anxiety and Depression Scale: Deutsche Version. Bern: Hu-ber; 1995.
19. Logan J, Fowler JS, Volkow ND, et al. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16:834-840.
20. Lochmann M, Buchholz HG, Siessmeier T, Schrecken-berger M, Rösch F, Bartenstein P. Comparison of different quantification methods for calculating binding potential (BP) of the new unselective opiate-receptor ligand F-18 fluor-ethyl-diprenorphine. J Cereb Blood Flow Metab 2003;23 suppl 1:669.
21. Sadzot B, Price JC, Mayberg HS, et al. Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography. J Cereb Blood Flow Metab 1991;11: 204-219.
22. Spilker ME, Sprenger T, Valet M, et al. Quantification of [18F]diprenorphine kinetics in the human brain with compartmental and non-compartmental modeling approaches. Neuroimage 2004;22:1523-1533.
23. Worsley KJ, Evans AC, Marrett S, Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 1992;12:900-918.
24. Neugebauer V, Li W, Bird GC, Han JS. The amygdala and persistent pain. Neuroscientist 2004;10:221-234.
25. Neugebauer V, Li W. Processing of nociceptive mechanical and thermal information in central amygdala neurons with knee-joint input. J Neurophysiol 2002;87:103-112.
26. Bingel U, Quante M, Knab R, et al. Subcortical structures involved in pain processing: evidence from single-trial fMRI. Pain 2002;99:313-321.
27. Helmstetter FJ, Tershner SA, Poore LH, Bellgowan PS. An-tinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res 1998;779:104-118.
28. Seifert F, Kiefer G, De-Col R, et al. Differential endogenous pain modulation in complex-regional pain syndrome. Brain 2009;132:788-800.
29. Harke H, Gretenkort P, Ladleif HU, Rahman S, Harke O. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. Anesth Analg 2001;92:488-495.
30. Jones AK, Kitchen ND, Watabe H, et al. Measurement of changes in opioid receptor binding in vivo during trigemi-nal neuralgic pain using [11C] diprenorphine and positron emission tomography. J Cereb Blood Flow Metab 1999; 19:803-808.
31. Maarrawi J, Peyron R, Mertens P, et al. Differential brain opioid receptor availability in central and peripheral neuropathic pain. Pain 2007;127:183-194.
32. Wager TD, Scott DJ, Zubieta J. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci USA 2007;104:11056-11061.
33. Ploghaus A, Becerra L, Borras C, Borsook D. Neural circuitry underlying pain modulation: expectation, hypnosis, placebo. Trends Cogn Sci 2003;7:197-200.
34. Geha PY, Baliki MN, Harden RN, et al. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 2008; 60:570-581.
35. Gündel H, Valet M, Sorg C, et al. Altered cerebral response to noxious heat stimulation in patients with so-matoform pain disorder. Pain 2008;137:413-421.
36. Zubieta J, Ketter TA, Bueller JA, et al. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry 2003; 60:1145-1153.
37. Ploghaus A, Narain C, Beckmann CF, et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci 2001;21:9896-9903.
38. Narita M, Kaneko C, Miyoshi K, et al. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 2006;31:739-750.